Clinical and Therapeutic Features of Nonpostoperative Nosocomial Intra-abdominal Infections

Annals of Surgery

Volumn 239, Issue 3, 2004, Pages 409-416

  Montravers, Philippe ^a   Chalfine, Annie ^b   Gauzit, Remy ^a   Lepape, Alain ^c   Marmuse, Jean Pierre ^d   Vouillot, Corinne ^a   Martin, Claude ^e  

^a HÔPITAL JEAN VERDIER   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d BICHAT HOSPITAL   (France)

^e HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGERY; SURGICAL WARD;

ABDOMEN; ADULT; ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 1242318825     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000114214.68169.e9     Document Type: Article

References (29)

1. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis: Mosby; 1996:A-1-A-20.
2. Carlet J, Goldstein FW, Bleriot JP, et al. Timentin in the antimicrobial treatment of nosocomial and polymicrobial infections. J Antimicrob Chemother. 1986;17:149-159.
3. Dupont H, Carbon C, Carlet J, et al. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. Antimicrob Agents Chemother. 2000;44:2028-2033.
4. Schoeffel U, Jacobs E, Ruf G, et al. Intraperitoneal micro-organisms and the severity of peritonitis. Eur J Surg. 1995;161:501-508.
5. Sawyer RG, Rosenlof LK, Adams RB, et al. Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am Surg. 1992;58:82-87.
6. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med. 1962;110:847-864.
7. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPSII) based on a European-North American multicenter study. JAMA. 1993;270:29057-29068.
8. Bohnen JM, Solomkin JS, Dellinger EP, et al. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. Arch Surg. 1992;127:83-89.
9. Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect. 2002;3:175-233.
10. Montravers P, Veber B, Auboyer C, et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole Study. Crit Care Med. 2002;30:368-375.
11. Hecht DW, Osmolski JR, O'Keefe JP. Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals. Clin Infect Dis. 1993;16(suppl 4):S357-S360.
12. Fluit AC, Jones ME, Schmitz FJ, et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis. 2000;30:454-460.
13. Jury's recommendations. Management of community-acquired peritonitis-Consensus conference-Short text. Ann Fr Anesth Reanim. 2001; 20:368s-373s.
14. Pitcher WD, Musher DM. Critical importance of early diagnosis and treatment of intra-abdominal infection. Arch Surg. 1982;117:328-333.
15. Bohnen J, Boulanger M, Meakins J, et al. Prognosis in generalized peritonitis: relation to cause and risk factors. Arch Surg. 1983;118:285-290.
16. Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg. 1996;131: 641-645.
17. Rosenblatt JE, Brook I. Clinical relevance of susceptibility testing of anaerobic bacteria. Clin Infect Dis. 1993;16:S446-S448.
18. Mosdell DM, Morris DM, Voltura A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991;214:543-549.
19. Dougherty SH, Saltzein EC, Peacock JB, et al. Perforated or gangrenous appendicitis treated with aminoglycosides. Arch Surg. 1989;124:1280-1283.
20. Christou NV, Turgeon P, Wassef R, et al. Management of intraabdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. Arch Surg. 1996;131:1193-1201.
21. Wilson SE, Huh J. In defense of routine antimicrobial susceptibility testing of operative site flora in patients with peritonitis. Clin Infect Dis. 1997;25:S254-S257.
22. Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet. 1989;ii:1437-1440.
23. Ho JL, Barza M. Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Antimicrob Agents Chemother. 1987;31:485-491.
24. Simmen HP, Battaglia H, Kossmann T, et al. Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections. World J Surg. 1993;17:393-397.
25. Vanjak D, Muller-Serieys C, Picard B, et al. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents. Eur J Clin Microbiol Infect Dis. 1995;14:972-978.
26. Hopkins JA, Lee JC, Wilson SE. Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection. Am Surg. 1993;59:791-796.
27. Koperna T, Schulz F. Prognosis and treatment of peritonitis. Arch Surg. 1996;131:180-186.
28. Montravers P, Gauzit R, Muller C, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23:486-494.
29. Roehrborn A, Thomas L, Potreck O, et al. The microbiology of postoperative peritonitis. Clin Infect Dis. 2002;33:1513-1519.